RxDoctor Payments Data

Kasi Hudson, APRN

Family · Pittsburg, KSNPI 1417333220

Payments from drug & device makers

$2,850in general payments, 2019–2025

Across 180 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$707
  • E.r. Squibb & Sons, L.L.C.$687
  • Johnson & Johnson$571
  • Lilly USA, LLC$229
  • Amgen$192
  • Novartis$185
  • plus $278 from 10 others

What the payments were for

  • Food & beverage$2,50788%
  • Education$34412%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,850 in reported general payments places this provider in the 90th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$173,383
Medicare patients
892
Services billed
3,543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa15$310,031
Cosentyx Sensoready (2 Pens)Secukinumab31$276,183
Humira(Cf) PenAdalimumab23$163,169
OtezlaApremilast24$118,839
Dupixent PenDupilumab22$82,910
Clobetasol Propionate92$6,800
Fluorouracil73$5,933
Clindamycin Phosphate27$2,181
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc131$2,042
Ketoconazole122$2,009
Tretinoin19$1,887
Triamcinolone Acetonide150$1,334
Metronidazole14$1,115
Doxycycline Hyclate49$927
Dapsone24$875

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$192$118,83924 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,579 family providers in Kansas.

Other family in Pittsburg

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →